- Home
- HPK vs OPK Comparison
HPK vs OPK Comparison
Compare HPK & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HPK | OPK |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | HPK | OPK |
|---|---|---|
| Price | $8.80 | $1.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 669.5K | ★ 4.0M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $863,359,000.00 | $606,879,000.00 |
| Revenue This Year | $12.23 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.85 | $0.98 |
| 52 Week High | $12.03 | $1.77 |
Technical Indicators
Market Signals| Indicator | HPK | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 62.63 |
| Support Level | $7.38 | $1.10 |
| Resistance Level | $12.03 | $1.75 |
| Average True Range (ATR) | 0.72 | 0.09 |
| MACD | -0.22 | 0.02 |
| Stochastic Oscillator | 3.31 | 85.11 |
Price Performance
Historical ComparisonAbout HPK HighPeak Energy Inc.
HighPeak Energy Inc is an independent crude oil and natural gas exploration and production company that explores for, develops and produces crude oil, NGL, and natural gas prominently in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S. The majority of the company's revenue is derived from the Crude oil sales.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.